Home
Storia in 1 fonti
Strides Pharma Science Q1 PAT rises 56.7% to ₹165.5 cr
Strides Pharma Science Ltd on Friday reported a 56.7 per cent rise in profit after tax at Rs 165.5 crore in the first quarter ended June 30, on the back of strong growth in markets excluding the US.
Raccontata da
thehindubusinessline.com
Timeline cronologica
- ·
Ajanta Pharma Q1 results: PAT rises 31% to ₹334 cr
Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to ₹334 crore for the first quarter ended June 30.
- ·
Strides Pharma Science Q1 PAT rises 56.7% to ₹165.5 cr
Strides Pharma Science Ltd on Friday reported a 56.7 per cent rise in profit after tax at Rs 165.5 crore in the first quarter ended June 30, on the back of strong growth in…
- ·
Sun Pharma posts higher quarterly profit on strong demand
Consolidated net profit in Q1 rises to ₹2,895 crore ($303.54 million) from ₹2,279 crore a year earlier